Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Original Research Article

Free Access

The Reliability and Validity of the Mini-Mental State Examination in the Elderly Croatian Population

Boban M.a,b · Malojčić B.a,b · Mimica N.b,c · Vuković S.b · Zrilić I.b · Hof P.R.e · Šimić G.b,d

Author affiliations

aDepartment of Cognitive Neurology, University Hospital Centre, bSchool of Medicine, University of Zagreb, cUniversity Psychiatric Hospital Vrapče, and dCroatian Institute for Brain Research, Zagreb, Croatia; eMount Sinai School of Medicine, New York, N.Y., USA

Corresponding Author

Marina Boban, MD, PhD

University Department of Cognitive Neurology

Zagreb School of Medicine and University Hospital Centre

Kišpatićeva 12, HR–10000 Zagreb (Croatia)

Tel. +385 91 539 5594, E-Mail maboban@mef.hr

Related Articles for ""

Dement Geriatr Cogn Disord 2012;33:385–392

Do you have an account?

Login Information

Contact Information

I have read the Karger Terms and Conditions and agree.


Aim: The aim of this study was standardization and validation of the Mini-Mental State Examination (MMSE) in the general Croatian aging population. Methods: Three-hundred and forty-four participants underwent the MMSE test, 217 cognitively healthy subjects without neurological and psychiatric disorders and 127 patients with mild cognitive impairment (MCI) or dementia. Results: The optimal cutoff point for screening of the general Croatian population (cognitively healthy vs. MCI and dementia) is 26/27; in the Croatian population aged ≥65 years, the cutoff point is 24/25, whereas for screening of highly educated persons (≥14 years of education) aged ≥65 years a higher cutoff point should be used (26/27). Conclusions: MMSE results when standardized and validated in a certain population might better contribute to recognition of the individuals at risk that should be directed to dementia outpatient clinics.

© 2012 S. Karger AG, Basel

Article / Publication Details

First-Page Preview
Abstract of Original Research Article

Accepted: May 21, 2012
Published online: July 17, 2012
Issue release date: August 2012

Number of Print Pages: 8
Number of Figures: 3
Number of Tables: 3

ISSN: 1420-8008 (Print)
eISSN: 1421-9824 (Online)

For additional information: https://www.karger.com/DEM

Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.